/Companies

Inmunoregulacion

Madrid, ES · 1 known investors

Find your way into Inmunoregulacion

Sign up to find every way you can get introduced to Inmunoregulacion

  • Your email: who you already know at Inmunoregulacion, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Inmunoregulacion team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

The Laboratory of Immuno-Regulation (LIR) is a research group at the Gregorio Marañón Hospital Health Research Institute in Madrid that studies regulatory T cells and thymic tissue for treating autoimmune diseases and transplant rejection. Its work includes cell-based therapies and has led to a biotech spin-off, Thytech.

Investors · 1

Frequently asked questions

What does Inmunoregulacion do?
The Laboratory of Immuno-Regulation (LIR) is a research group at the Gregorio Marañón Hospital Health Research Institute in Madrid that studies regulatory T cells and thymic tissue for treating autoimmune diseases and transplant rejection. Its work includes cell-based therapies and has led to a biotech spin-off, Thytech.
Who are Inmunoregulacion's investors?
Inmunoregulacion's investors include BStartup.
Where is Inmunoregulacion headquartered?
Inmunoregulacion is headquartered in Madrid, ES.